| Authors: |
Smith A; Department of Investigative Toxicology, Non Clinical Safety Assessment and Pathology, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA. smithat@lilly.com., Calley J; Department of TTX Bioinformatics, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA., Mathur S; Department of TTX Bioinformatics, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA., Qian HR; Department of Discovery and Development Statistics, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA., Wu H; Department of Discovery and Development Statistics, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA., Farmen M; Department of Discovery and Development Statistics, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA., Caiment F; Department of Toxicogenomics, Maastricht University, Universiteitsingel, Maastricht, The Netherlands., Bushel PR; National Institute of Environmental Health Sciences, Biostatistics Branch, Durham, NC, USA., Li J; Kelly Government Solutions, Research Triangle Park, Durham, NC, 27709, USA., Fisher C; Drug Safety Evaluation, Takeda Pharmaceuticals International Company, Deerfield, USA., Kirby P; Drug Safety Evaluation, Takeda Pharmaceuticals International Company, Deerfield, USA., Koenig E; Molecular Pathology, Takeda Pharmaceuticals International Company, Deerfield, USA., Hall DG; Department of Investigative Pathology, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA., Watson DE; Department of Investigative Toxicology, Non Clinical Safety Assessment and Pathology, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, 46285, IN, USA. |
